Operating income increased 41.5%
Operating income changed +41.5% from the comparable as-filed period.
$325.0M→$460.0M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CLS financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue increased 82.5%
Revenue changed +82.5% from the comparable as-filed period.
$3.2B→$5.8B2 prior comparisons
Operating cash flow increased 208.8%
Operating cash flow changed +208.8% from the comparable as-filed period.
$126.2M→$389.7M2 prior comparisons
Operating margin moved 228 bp lower
Operating margin changed -228 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
10.18%→7.89%2 prior comparisons
Free-cash-flow proxy increased 30.0%
Free-cash-flow proxy changed +30.0% from the comparable as-filed period.
$88.9M→$115.6M2 prior comparisons
Net income increased 48.3%
Net income changed +48.3% from the comparable as-filed period.
$267.8M→$397.2M2 prior comparisons
Gross margin moved 204 bp lower
Gross margin changed -204 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
13.03%→10.99%2 prior comparisons
Cost of revenue increased 86.8%
Cost of revenue changed +86.8% from the comparable as-filed period.
$2.8B→$5.2B2 prior comparisons
Total assets increased 129.1%
Total assets changed +129.1% from the comparable as-filed period.
$6.6B→$15.1B3 prior comparisons
Inventory increased 120.3%
Inventory changed +120.3% from the comparable as-filed period.
$2.0B→$4.5B3 prior comparisons
Inventory / revenue moved 1328 bp higher
Inventory / revenue changed +1328 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
64.08%→77.36%2 prior comparisons
Current liabilities increased 121.8%
Current liabilities changed +121.8% from the comparable as-filed period.
$3.5B→$7.8B3 prior comparisons
Current assets increased 143.9%
Current assets changed +143.9% from the comparable as-filed period.
$5.1B→$12.5B3 prior comparisons
Selling, general & administrative increased 207.8%
Selling, general & administrative changed +207.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$38.4M→$118.2M2 prior comparisons
Working capital increased 191.0%
Working capital changed +191.0% from the comparable as-filed period.
$1.6B→$4.8B3 prior comparisons
Research & development increased 40.7%
Research & development changed +40.7% from the comparable as-filed period.
$36.4M→$51.2M2 prior comparisons
Capex / revenue moved 353 bp higher
Capex / revenue changed +353 basis points from the comparable as-filed period.
1.17%→4.70%2 prior comparisons
Operating cash flow increased 169.6%
Operating cash flow changed +169.6% from the comparable as-filed period.
$152.4M→$410.9M2 prior comparisons
Revenue increased 62.4%
Revenue changed +62.4% from the comparable as-filed period.
$2.9B→$4.7B2 prior comparisons
Operating income increased 68.2%
Operating income changed +68.2% from the comparable as-filed period.
$272.5M→$458.3M2 prior comparisons
Net income increased 74.8%
Net income changed +74.8% from the comparable as-filed period.
$211.0M→$368.8M2 prior comparisons
Cost of revenue increased 63.4%
Cost of revenue changed +63.4% from the comparable as-filed period.
$2.5B→$4.1B2 prior comparisons
Current assets increased 58.8%
Current assets changed +58.8% from the comparable as-filed period.
$4.8B→$7.6B3 prior comparisons
Current liabilities increased 86.1%
Current liabilities changed +86.1% from the comparable as-filed period.
$3.3B→$6.2B3 prior comparisons
Inventory increased 77.3%
Inventory changed +77.3% from the comparable as-filed period.
$1.9B→$3.4B3 prior comparisons
Total assets increased 56.8%
Total assets changed +56.8% from the comparable as-filed period.
$6.2B→$9.8B3 prior comparisons
Inventory / revenue moved 611 bp higher
Inventory / revenue changed +611 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
66.29%→72.40%2 prior comparisons
Cash & equivalents increased 70.7%
Cash & equivalents changed +70.7% from the comparable as-filed period.
$313.8M→$535.7M3 prior comparisons
Free-cash-flow proxy increased 22.7%
Free-cash-flow proxy changed +22.7% from the comparable as-filed period.
$119.9M→$147.1M2 prior comparisons
Net debt decreased 53.6%
Net debt changed -53.6% from the comparable as-filed period.
$534.8M→$248.3M3 prior comparisons
Research & development increased 36.2%
Research & development changed +36.2% from the comparable as-filed period.
$34.0M→$46.3M2 prior comparisons
Capex / revenue moved 449 bp higher
Capex / revenue changed +449 basis points from the comparable as-filed period.
1.12%→5.61%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.